In the joint project “Therapeutic Stromal Cells for Health in Space”, Israel’s Pluristem Therapeutics and NASA’s Ames Research Center will evaluate the potential of Pluristem’s PLX cell therapies to prevent and treat medical conditions caused during space missions.
http://www.pluristem.com/wp-content/uploads/2019/02/Pluristem_NASA_final_isa.pdf